“…Objectives: Appropriateness of device selection, procedure protocol and aortic remodeling effects of entry closure (TEVAR) with stent-graft (SG) for patent false lumen type B aortic dissection (TBAD) were compared between the patients with narrow true lumen (narrow group) and those with aneurysmal dilated false lumen (aneurysmal group). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the univariate analysis, a thinner choroid was associated with decreased growth velocity (P < 0.001), lower birth weight (P < 0.001), smaller head circumference (P < 0.001), younger gestational age (P = 0.01), the presence of patent ductus arteriosus (P = 0.05), sepsis or necrotizing enterocolitis (P = 0.03), bronchopulmonary dysplasia (P = 0.03), pulmonary interstitial emphysema (P = 0.002), more days on oxygen support (P < 0.001), and being on oxygen support at 36 weeks (P < 0.001) and at the time of imaging (P < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background. Stenting of patent ductus arteriosus (PDA) is a minimally invasive catheter-based temporary palliative procedure that is an alternative to a surgical shunt in neonates with duct-dependent pulmonary perfusion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Two juice samples were collected from the plant blossom: The first sample was prepared with 1% filtered water through a patented EVOdrop device. Then the sample was saturated with hydrogen with EVOdrop booster to a concentration of 1.2 ppm, pH = 7.3, ORP = −390 mV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The eight main categories are vaccination (53.72%), evaluation and impact of other social events (17.90%), vaccine R&D and listing (9.49%), vaccine side effects and countermeasures (5.63%), vaccination necessity (4.98%), vaccine patent exemption (3.26%), vaccination effectiveness (2.94%), and essential knowledge of vaccine (2.08%), where percentage refers to the distribution of information needs data under various categories. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, normal lungs with normal patent alveoli were detected 72 h following treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To analyze the alternation of sinusoidal spaces, micro-dissected CC explants by patent blue dye injection were incubated and examined for their structural alternations during relaxation/contraction. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Also, we discuss Chinese patent medicines and plant extracts that could induce metal-dependent programmed cell death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The corrosion rate of the samples was investigated using an electrochemical setup, especially adjusted to evaluate these types of samples, and thus, helped to improve an already patented coating process. A MgF(2)/MgO coating in the µm-range was characterized for the first time using complementary techniques. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Given recent expiration of patent protection of biologics, a shift toward greater follow-on competition among biosimilars would be expected that would allow greater uptake and lower drug costs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cancer treatment was associated with decreased risk (surgery: HR= 0.60, p<0.001; chemotherapy: HR=0.42, p<0.001; radiation: HR= 0.69, p<0.05). However, among patents surviving five years or more from cancer diagnosis radiotherapy was associated with higher risk of cerebrovascular mortality (HR 2.73, 95% CI 1.49-4.99, p<0.01). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We described in this study the case of a young aura migraineur female patient without HHT in whom isolated PAVM below the detection limit of pulmonary angiography and chest computed tomography angiography (CTA) has been documented by contrast Transthoracic and Transesophageal Echocardiography (cTTE/TEE) showing a delayed (>17 s) RLS coming from left pulmonary veins to left atrium while a patent foramen ovale (PFO), small atrial septal defects or septum primum fenestration could not be detected despite several attempts. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…WHAT IS NEW AND THE CONCLUSION: The entry of generics and biosimilars will now be encouraged by brand‐name product companies, reducing the intellectual property hurdles like the “patent dance” for biosimilars. The IRA includes restrictions to prevent the brand name companies from exploiting the entry of generics and biosimilars to assure their independence.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…These measures should account for the particularities of off-patent biologic and biosimilar markets and should jointly address supply- and demand-side challenges.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A VUC at 30 days showed a patent bladder neck. Incontinence was 3 pads/day after catheter removal and decreased to 1 pad/day after 180 days. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Our findings demonstrate that off-patent medications can skyrocket in price, especially when there are few manufacturers of a given medication.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There were no significant differences between groups in frequencies of bronchopulmonary dysplasia, necrotizing enterocolitis and patent ductus arteriosus. Conclusions: Less invasive surfactant administration methods seem to have advantages regarding early need for mechanical ventilation, decreasing morbidities and death rate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A completion angiography demonstrated a patent popliteal artery with a 2-vessels patency to the foot. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All patients were asymptomatic, with patent CFAs, at last follow-up. There was 1 case of surgical site restenosis and 1 reintervention for remote stenosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The aim of this study was to evaluate the efficacy of a patent-pending formulation (Pelvipea(®)) composed of micronized palmitoylethanolamide (PEA), hempseed oil, and maritime pine bark dry extract in reducing urothelial inflammation, as well as the effect of each ingredient individually, in order to define the synergistic effect of the three ingredients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso